Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with von Jorg-Peter Kleim, Winters, Mark, Dunkler, Anke, Jose-Ramon Suarez

Volltext

Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline... von Pelemans, H, Esnouf, R, Dunkler, A, Parniak, M A, Vandamme, A M, Karlsson, A, De Clercq, E, Kleim, J P, Balzarini, J

Volltext

Antiviral Activity of the Human Immunodeficiency Virus Type 1—Specific Nonnucleoside Reverse Transcriptase Inhibitor HBY 097 Alone and in Combination with Zidovudine in a Phase II... von Kleim, Jörg-Peter, Winters, Mark, Dunkler, Anke, Suarez, José-Ramon, Rieß, Günther, Winkler, Irvin, Balzarini, Jan, Oette, Dagmar, Merigan, Thomas C.

Volltext